Nierenzellkarzinom. Vom symptom zur therapie

Inga Peters; A. S. Merseburger; M. A. Kuczyk

Nierenzellkarzinom. Vom symptom zur therapie

Translated title of the contribution: Renal cell cancer. From symptoms to therapy

Inga Peters, A. S. Merseburger, M. A. Kuczyk^*

^*Corresponding author for this work

Clinic of Urology

Hannover Medical School

Abstract

Renal cell cancer is one of the tenth most frequent tumor-dependent causes of death worldwide. In localized stages surgical therapy is the only curative option for the patient. If a renal cell carcinoma is diagnosed in late, i.e. advanced/metastasized stages a drug therapy with targeted agents following tumor burden surgery is nowadays the best option to increase patients progression-free survival. Whenever possible, a partial resection should be perform in regard to decrease rates of longtime renal failure.

Translated title of the contribution	Renal cell cancer. From symptoms to therapy
Original language	German
Journal	Internistische Praxis
Volume	52
Issue number	3
Pages (from-to)	539-545
Number of pages	7
ISSN	0020-9570
Publication status	Published - 09.2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Areas and Centers

Research Area: Luebeck Integrated Oncology Network (LION)

Cite this

@article{20293ee97b9047e3a50017ad95f97406,

title = "Nierenzellkarzinom. Vom symptom zur therapie",

abstract = "Renal cell cancer is one of the tenth most frequent tumor-dependent causes of death worldwide. In localized stages surgical therapy is the only curative option for the patient. If a renal cell carcinoma is diagnosed in late, i.e. advanced/metastasized stages a drug therapy with targeted agents following tumor burden surgery is nowadays the best option to increase patients progression-free survival. Whenever possible, a partial resection should be perform in regard to decrease rates of longtime renal failure.",

author = "Inga Peters and Merseburger, \{A. S.\} and Kuczyk, \{M. A.\}",

year = "2012",

month = sep,

language = "Deutsch",

volume = "52",

pages = "539--545",

journal = "Internistische Praxis",

issn = "0020-9570",

publisher = "mgo fachverlage GmbH \& Co KG",

number = "3",

}

TY - JOUR

T1 - Nierenzellkarzinom. Vom symptom zur therapie

AU - Peters, Inga

AU - Merseburger, A. S.

AU - Kuczyk, M. A.

PY - 2012/9

Y1 - 2012/9

N2 - Renal cell cancer is one of the tenth most frequent tumor-dependent causes of death worldwide. In localized stages surgical therapy is the only curative option for the patient. If a renal cell carcinoma is diagnosed in late, i.e. advanced/metastasized stages a drug therapy with targeted agents following tumor burden surgery is nowadays the best option to increase patients progression-free survival. Whenever possible, a partial resection should be perform in regard to decrease rates of longtime renal failure.

AB - Renal cell cancer is one of the tenth most frequent tumor-dependent causes of death worldwide. In localized stages surgical therapy is the only curative option for the patient. If a renal cell carcinoma is diagnosed in late, i.e. advanced/metastasized stages a drug therapy with targeted agents following tumor burden surgery is nowadays the best option to increase patients progression-free survival. Whenever possible, a partial resection should be perform in regard to decrease rates of longtime renal failure.

UR - https://www.scopus.com/pages/publications/84864133192

M3 - Übersichtsarbeiten

AN - SCOPUS:84864133192

SN - 0020-9570

VL - 52

SP - 539

EP - 545

JO - Internistische Praxis

JF - Internistische Praxis

IS - 3

ER -

Nierenzellkarzinom. Vom symptom zur therapie

Abstract

UN SDGs

Research Areas and Centers

Other files and links

Fingerprint

Cite this